A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer’s COVID-19 vaccine, first at six months following a completed, two-dose regimen, and then with boosters. The first study maintains that despite a gradual decline in efficacy, the Pfizer vaccine remains highly effective in preventing COVID-19, with efficacy declining approximately 6% every two months after an initial peak effectiveness of 96.2%. The authors further state that ongoing observations through two years following initial doses will determine the likely benefits of a booster program.

The second study, based out of Israel, found that a third, booster dose of the Pfizer vaccine yielded strong protections for individuals age 60 and older, with substantially lower rates of COVID-19 and severe illness. The authors state that, based on their review of available data, a booster dose for those age 60 and older “reduces the rate of infection for such vaccine recipients by a factor of 10.”

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee will meet tomorrow to discuss Pfizer’s application for approval of a COVID-19 booster shot.
 

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…